| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 496 | 2024 |
| Global burden of cardiovascular diseases and risks, 1990-2022 GA Mensah, V Fuster, CJL Murray, GA Roth, ... Journal of the American College of Cardiology 82 (25), 2350-2473, 2023 | 492 | 2023 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 466 | 2024 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 465 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 297 | 2024 |
| Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: a systematic analysis for the Global … YH Shin, J Hwang, R Kwon, SW Lee, MS Kim, ... Allergy 78 (8), 2232-2254, 2023 | 163 | 2023 |
| Stigmatization of people with alcohol use disorders: An updated systematic review of population studies C Kilian, J Manthey, S Carr, F Hanschmidt, J Rehm, S Speerforck, ... Alcoholism: Clinical and Experimental Research 45 (5), 899-911, 2021 | 163 | 2021 |
| Health effects associated with smoking: a Burden of Proof study X Dai, GF Gil, MB Reitsma, NS Ahmad, JA Anderson, C Bisignano, S Carr, ... Nature medicine 28 (10), 2045-2055, 2022 | 119 | 2022 |
| What are the economic costs to society attributable to alcohol use? A systematic review and modelling study J Manthey, SA Hassan, S Carr, C Kilian, S Kuitunen-Paul, J Rehm Pharmacoeconomics 39 (7), 809-822, 2021 | 110 | 2021 |
| Use of alcohol, tobacco, cannabis, and other substances during the first wave of the SARS-CoV-2 pandemic in Europe: a survey on 36,000 European substance users J Manthey, C Kilian, S Carr, M Bartak, K Bloomfield, F Braddick, A Gual, ... Substance abuse treatment, prevention, and policy 16, 1-11, 2021 | 103 | 2021 |
| Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 VL Feigin, MD Abate, YH Abate, S Abd ElHafeez, F Abd-Allah, ... The Lancet Neurology 23 (10), 973-1003, 2024 | 88 | 2024 |
| Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global … RG Bender, SB Sirota, LR Swetschinski, RMV Dominguez, A Novotney, ... The Lancet Infectious Diseases 24 (9), 974-1002, 2024 | 54 | 2024 |
| Health effects associated with exposure to secondhand smoke: a Burden of Proof study LS Flor, JA Anderson, N Ahmad, A Aravkin, S Carr, X Dai, GF Gil, SI Hay, ... Nature medicine 30 (1), 149-167, 2024 | 38 | 2024 |
| Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021 JR Ledesma, J Ma, M Zhang, AVL Basting, HT Chu, A Vongpradith, ... The Lancet infectious diseases 24 (7), 698-725, 2024 | 33 | 2024 |
| Health effects associated with exposure to intimate partner violence against women and childhood sexual abuse: a burden of proof study CN Spencer, M Khalil, M Herbert, AY Aravkin, A Arrieta, MJ Baeza, ... Nature medicine 29 (12), 3243-3258, 2023 | 27 | 2023 |
| Estimating the economic consequences of substance use and substance use disorders J Manthey, SA Hassan, S Carr, C Kilian, S Kuitunen-Paul, J Rehm Expert Review of Pharmacoeconomics & Outcomes Research 21 (5), 869-876, 2021 | 21 | 2021 |
| Increased alcohol‐specific mortality in Germany during COVID‐19: State‐level trends from 2010 to 2020 C Kilian, S Carr, B Schulte, J Manthey Drug and Alcohol Review 42 (3), 633-640, 2023 | 18 | 2023 |
| Reduced alcohol consumption during the COVID-19 pandemic: Analyses of 17 000 patients seeking primary health care in Colombia and Mexico J Manthey, S Carr, P Anderson, N Bautista, F Braddick, A O’Donnell, ... Journal of global health 12, 05002, 2022 | 17* | 2022 |
| The predictive validity of a Brain Care Score for dementia and stroke: data from the UK Biobank cohort SD Singh, T Oreskovic, S Carr, K Papier, M Conroy, JR Senff, Z Chemali, ... Frontiers in Neurology 14, 1291020, 2023 | 11 | 2023 |
| Can alcohol consumption in Germany be reduced by alcohol screening, brief intervention and referral to treatment in primary health care? Results of a simulation study J Manthey, A Solovei, P Anderson, S Carr, J Rehm PLoS One 16 (8), e0255843, 2021 | 11 | 2021 |